Ze-Kun Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ze-Kun Li has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Ming-Jun Bi
Emergency Center, Yuhuangding Hospital Affiliated to Qingdao University, Yantai, Shandong 264000, China
3 shared publications - Qin Li
Emergency Department, Shenzhen University General Hospital, Shenzhen, Guangdong, China
3 shared publications - Xu-Dong Zhou
Department of Integration of Chinese and Western Medicine, Yantai Yuhuangding Hospital Affiliated to Qingdao University, Yantai, Shandong 264000, China
3 shared publications - Jing-Lin Wang
Emergency Center, Yuhuangding Hospital Affiliated to Qingdao University, Yantai, Shandong 264000, China
2 shared publications - Shao-Bin Zhang
Weifang Eye Hospital, Weifang, Shandong 261000, China
2 shared publications - Wei-Kang Bi
Weifang Medical University, Weifang, Shandong 261042, China
2 shared publications
Latest Publications
- 11 November 2021
- Published by Wiley in Environmental Toxicology
- Vol. 37 (3) , 413-434
Therapeutic effect and molecular mechanism of Salvia Miltiorrhiza on rats with acute brain injury after carbon monoxide poisoning based on the strategy of internet pharmacology
The pathogenesis of brain injury caused by carbon monoxide poisoning (COP) is very complex, and there is no exact and reliable treatment in clinic. In the present study, we screened the therapeutic target and related signal pathway of Salvia Miltiorrhiza for acute COP brain injury, and clarified the pharmacological mechanism of multicomponent, multitarget, and multisignal pathway in Salvia Miltiorrhiza by network pharmacology. To further verify the therapeutic effect of Salvia Miltiorrhiza on acute brain injury based on the results of network analysis, a total of 216 male healthy Sprague Dawley rats were collected in the present study and randomly assigned to a normal control group, a COP group and a Tanshinone IIA sulfonate treatment group (72 rats in each group). The rat model of acute severe COP was established by the secondary inhalation in a hyperbaric oxygen chamber. We found that Salvia Miltiorrhiza had multiple active components, and played a role in treating acute brain injury induced by COP through multiple targets and multiple pathways, among them, MAPK/ERK1/2 signaling pathway was one of the most important. COP can start apoptosis process, activate the MAPK/ERK1/2 signaling pathway, and promote the expression of VEGF‐A protein and the formation of brain edema. Tanshinone IIA can effectively inhibit apoptosis, up‐regulate the expressions of VEGF‐A, P‐MEK1/2 and P‐ERK1/2 proteins, thereby protect endothelial cells, promote angiogenesis and microcirculation, and finally alleviate brain edema.
- 11 November 2021
- Published by Wiley in Environmental Toxicology
- Vol. 37 (3) , 413-434
Therapeutic effect and molecular mechanism of Salvia Miltiorrhiza on rats with acute brain injury after carbon monoxide poisoning based on the strategy of internet pharmacology
The pathogenesis of brain injury caused by carbon monoxide poisoning (COP) is very complex, and there is no exact and reliable treatment in clinic. In the present study, we screened the therapeutic target and related signal pathway of Salvia Miltiorrhiza for acute COP brain injury, and clarified the pharmacological mechanism of multicomponent, multitarget, and multisignal pathway in Salvia Miltiorrhiza by network pharmacology. To further verify the therapeutic effect of Salvia Miltiorrhiza on acute brain injury based on the results of network analysis, a total of 216 male healthy Sprague Dawley rats were collected in the present study and randomly assigned to a normal control group, a COP group and a Tanshinone IIA sulfonate treatment group (72 rats in each group). The rat model of acute severe COP was established by the secondary inhalation in a hyperbaric oxygen chamber. We found that Salvia Miltiorrhiza had multiple active components, and played a role in treating acute brain injury induced by COP through multiple targets and multiple pathways, among them, MAPK/ERK1/2 signaling pathway was one of the most important. COP can start apoptosis process, activate the MAPK/ERK1/2 signaling pathway, and promote the expression of VEGF‐A protein and the formation of brain edema. Tanshinone IIA can effectively inhibit apoptosis, up‐regulate the expressions of VEGF‐A, P‐MEK1/2 and P‐ERK1/2 proteins, thereby protect endothelial cells, promote angiogenesis and microcirculation, and finally alleviate brain edema.
- Open Access
- 18 January 2021
- Published by Wiley in Journal of Ophthalmology
- Vol. 2021 (1) , 6287083
Corrigendum to “Clinical Characteristics of Visual Dysfunction in Carbon Monoxide Poisoning Patients”
In the article titled “Clinical Characteristics of Visual Dysfunction in Carbon Monoxide Poisoning Patients” [1], there was a spelling error in author Jing-Lin Wang’s name in the author list, where “Jin-Lin Wang” should have read as “Jing-Lin Wang.” This is corrected in the author list above.
- 18 January 2021
- Published by Wiley in Journal of Ophthalmology
- Vol. 2021 (1) , 6287083
Open AccessCorrigendum to “Clinical Characteristics of Visual Dysfunction in Carbon Monoxide Poisoning Patients”
In the article titled “Clinical Characteristics of Visual Dysfunction in Carbon Monoxide Poisoning Patients” [1], there was a spelling error in author Jing-Lin Wang’s name in the author list, where “Jin-Lin Wang” should have read as “Jing-Lin Wang.” This is corrected in the author list above.
- Open Access
- 22 September 2020
- Published by Wiley in Journal of Ophthalmology
- Vol. 2020, 1-8
Clinical Characteristics of Visual Dysfunction in Carbon Monoxide Poisoning Patients
Purpose. The aim of the present study was to analyze the clinical characteristics of visual dysfunction in patients with carbon monoxide (CO) poisoning. Methods. A total of 436 patients with CO poisoning were enrolled in our hospital from October 2012 to December 2018, including 193 patients with moderate poisoning (MP group), 165 with severe poisoning (SP group), and 78 with delayed encephalopathy (DE group). The clinical characteristics of visual dysfunction in patients with CO poisoning were analyzed through the collection of medical history, regular physical examination, brain magnetic resonance imaging (MRI), ophthalmological examination, the National Eye Institute Visual Function Questionnaire (NEI-VFQ), and its influencing factors. Results. Some patients in the three groups had visual dysfunction. The main ocular symptoms were local pain, eye movement disorder, and visual field defect. The key pathological factors were keratopathy, retinal nerve cell damage, optic nerve damage, retinal vascular disease, macular disease, and occipital visual center damage. The clinical symptoms of visual dysfunction after CO poisoning lasted for a long time (>12 months) and were not completely consistent with the positive results of the ophthalmological examination. A few sequelae of ophthalmology were still left after the help of medicine. Conclusion. The incidence of visual dysfunction in patients with CO poisoning was high, the clinical symptoms were rich and diverse, the duration of disease was long, and the prognosis was poor. Thus, the relevant ophthalmological examination and intervention treatment should be perfected as soon as possible.
- 22 September 2020
- Published by Wiley in Journal of Ophthalmology
- Vol. 2020, 1-8
Open AccessClinical Characteristics of Visual Dysfunction in Carbon Monoxide Poisoning Patients
Purpose. The aim of the present study was to analyze the clinical characteristics of visual dysfunction in patients with carbon monoxide (CO) poisoning. Methods. A total of 436 patients with CO poisoning were enrolled in our hospital from October 2012 to December 2018, including 193 patients with moderate poisoning (MP group), 165 with severe poisoning (SP group), and 78 with delayed encephalopathy (DE group). The clinical characteristics of visual dysfunction in patients with CO poisoning were analyzed through the collection of medical history, regular physical examination, brain magnetic resonance imaging (MRI), ophthalmological examination, the National Eye Institute Visual Function Questionnaire (NEI-VFQ), and its influencing factors. Results. Some patients in the three groups had visual dysfunction. The main ocular symptoms were local pain, eye movement disorder, and visual field defect. The key pathological factors were keratopathy, retinal nerve cell damage, optic nerve damage, retinal vascular disease, macular disease, and occipital visual center damage. The clinical symptoms of visual dysfunction after CO poisoning lasted for a long time (>12 months) and were not completely consistent with the positive results of the ophthalmological examination. A few sequelae of ophthalmology were still left after the help of medicine. Conclusion. The incidence of visual dysfunction in patients with CO poisoning was high, the clinical symptoms were rich and diverse, the duration of disease was long, and the prognosis was poor. Thus, the relevant ophthalmological examination and intervention treatment should be perfected as soon as possible.